The ameliorative effect of Piper trioicum in attenuating cognitive deficit in scopolamine induced neurotoxicity in experimental rats.

[1]  A. K. Sahoo,et al.  Hydrolea zeylanica improves cognitive impairment in high-fat diet fed-streptozotocin-induced diabetic encephalopathy in rats via regulating oxidative stress, neuroinflammation, and neurotransmission in brain , 2022, Heliyon.

[2]  E. Levitan,et al.  Calcium/Calmodulin–Dependent Protein Kinase II in Cerebrovascular Diseases , 2021, Translational Stroke Research.

[3]  A. B. Jena,et al.  Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies , 2021, Scientific reports.

[4]  B. B. Borse,et al.  Neuroprotective Effect of Spice Oleoresins on Memory and Cognitive Impairment Associated with Scopolamine-Induced Alzheimer’s Disease in Rats , 2020, ACS omega.

[5]  G. Agbor,et al.  Scopolamine-Induced Memory Impairment in Mice: Neuroprotective Effects of Carissa edulis (Forssk.) Valh (Apocynaceae) Aqueous Extract , 2020, International journal of Alzheimer's disease.

[6]  K. Abe,et al.  Prevention of Cognitive Decline in Alzheimer’s Disease by Novel Antioxidative Supplements , 2020, International journal of molecular sciences.

[7]  S. Mishra,et al.  Neuroprotective effect of Reinwardtia indica against scopolamine induced memory-impairment in rat by attenuating oxidative stress , 2020, Metabolic Brain Disease.

[8]  Satish Kanhar,et al.  Ameliorative effects of Hydrolea zeylanica in streptozotocin-induced oxidative stress and metabolic changes in diabetic rats. , 2020, Journal of ethnopharmacology.

[9]  S. Ray,et al.  Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer’s disease , 2019, Neural regeneration research.

[10]  Iekhsan Othman,et al.  Ethanolic Extract of Orthosiphon stamineus Improves Memory in Scopolamine-Induced Amnesia Model , 2019, Front. Pharmacol..

[11]  Luca Pinzi,et al.  Molecular Docking: Shifting Paradigms in Drug Discovery , 2019, International journal of molecular sciences.

[12]  Hyeonseok S. Jeong,et al.  Effects of nicergoline treatment on regional cerebral blood flow in early Alzheimer's disease , 2019, Int. J. Imaging Syst. Technol..

[13]  P. Tsvetkov,et al.  Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects , 2019, Front. Aging Neurosci..

[14]  A. Dixit,et al.  Isolation, identification, and quantification of Pentylcurcumene from Geophila repens: A new class of cholinesterase inhibitor for Alzheimer's disease. , 2019, Bioorganic chemistry.

[15]  J. Kurzepa,et al.  Betulin and betulinic acid: triterpenoids derivatives with a powerful biological potential , 2019, Phytochemistry Reviews.

[16]  Qinglin Li,et al.  Cardioprotective role of azafrin in against myocardial injury in rats via activation of the Nrf2-ARE pathway. , 2018, Phytomedicine.

[17]  J. Bandyopadhyay,et al.  Multi-functional neuroprotective activity of neohesperidin dihydrochalcone: a novel scaffold for Alzheimer's disease therapeutics identified via drug repurposing screening , 2018 .

[18]  Satish Kanhar,et al.  The ameliorative effect of Homalium nepalense on carbon tetrachloride-induced hepatocellular injury in rats. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[19]  Mahabir P. Gupta,et al.  Ethnomedical uses and pharmacological activities of most prevalent species of genus Piper in Panama: A review. , 2018, Journal of ethnopharmacology.

[20]  Satish Kanhar,et al.  Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease. , 2018, Journal of ethnopharmacology.

[21]  Esrafil Mansouri,et al.  The effects of betulinic acid on neurobehavioral activity, electrophysiology and histological changes in an animal model of the Alzheimer’s disease , 2018, Behavioural Brain Research.

[22]  A. McDonald,et al.  Neuropharmacological profile and chemical analysis of fresh rhizome essential oil of Curcuma longa (turmeric) cultivated in Southwest Nigeria , 2017, Toxicology reports.

[23]  L. Cuppari,et al.  Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial , 2017, PloS one.

[24]  A. K. Sahoo,et al.  In vitro antioxidant assessment and a rapid HPTLC bioautographic method for the detection of anticholinesterase inhibitory activity of Geophila repens. , 2017, Journal of integrative medicine.

[25]  H. J. Olguín,et al.  Oleic Acid Protects Against Oxidative Stress Exacerbated by Cytarabine and Doxorubicin in Rat Brain. , 2016, Anti-cancer agents in medicinal chemistry.

[26]  Debomoy K Lahiri,et al.  Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease. , 2016, Current Alzheimer research.

[27]  A. Makarov,et al.  Direct interaction of beta-amyloid with Na,K-ATPase as a putative regulator of the enzyme function , 2016, Scientific Reports.

[28]  H. M. Ali,et al.  New Indole Alkaloids from the Bark of Rauvolfia Reflexa and their Cholinesterase Inhibitory Activity , 2015, Cellular Physiology and Biochemistry.

[29]  Jayanthi Mk,et al.  Preventive role of Indian black pepper in animal models of Alzheimer's disease. , 2015, Journal of clinical and diagnostic research : JCDR.

[30]  Chi-Tang Ho,et al.  Oleic acid ameliorates Aβ-induced inflammation by downregulation of COX-2 and iNOS via NFκB signaling pathway , 2015 .

[31]  L. Tan,et al.  Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease. , 2015, Annals of translational medicine.

[32]  J. Kuret,et al.  Structure and mechanism of action of tau aggregation inhibitors. , 2014, Current Alzheimer research.

[33]  Se Jin Park,et al.  Amyrin attenuates scopolamine-induced cognitive impairment in mice. , 2014, Biological & pharmaceutical bulletin.

[34]  V. Cavallaro,et al.  Send Orders of Reprints at Reprints@benthamscience.net Natural Ache Inhibitors from Plants and Their Contribution to Alzheimer's Disease Therapy , 2022 .

[35]  V. Vasić,et al.  Send Orders of Reprints at Reprints@benthamscience.net Acetylcholinesterase Inhibitors: Pharmacology and Toxicology , 2022 .

[36]  J. S. da Silva,et al.  An overview of the modulatory effects of oleic acid in health and disease. , 2013, Mini reviews in medicinal chemistry.

[37]  J. McGrath,et al.  Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease , 2013, Frontiers in Neuroendocrinology.

[38]  Omer Kalayci,et al.  Oxidative Stress and Antioxidant Defense , 2012, The World Allergy Organization journal.

[39]  E. Perry,et al.  Medicinal Plants and Dementia Therapy: Herbal Hopes for Brain Aging? , 2011, CNS neuroscience & therapeutics.

[40]  R. Rozmahel,et al.  Oleic Acid Ameliorates Amyloidosis in Cellular and Mouse Models of Alzheimer's Disease , 2011, Brain pathology.

[41]  R. Yegnanarayan,et al.  Study of CNS depressant and behavioral activity of an ethanol extract of Achyranthes Aspera (Chirchita) in mouse model , 2011, Annals of neurosciences.

[42]  D. Souza,et al.  Caffeine prevents disruption of memory consolidation in the inhibitory avoidance and novel object recognition tasks by scopolamine in adult mice , 2010, Behavioural Brain Research.

[43]  E. Kravitz,et al.  Octopamine Neuromodulatory Effects on a Social Behavior Decision-Making Network in Drosophila Males , 2010, PloS one.

[44]  Maree T. Smith,et al.  Comparative studies of the neuro-excitatory behavioural effects of morphine-3-glucuronide and dynorphin A(2-17) following spinal and supraspinal routes of administration , 2009, Pharmacology Biochemistry and Behavior.

[45]  U. Bavendiek,et al.  Digitoxin elicits anti-inflammatory and vasoprotective properties in endothelial cells: Therapeutic implications for the treatment of atherosclerosis? , 2009, Atherosclerosis.

[46]  A. Ennaceur,et al.  Do rats really express neophobia towards novel objects? Experimental evidence from exposure to novelty and to an object recognition task in an open space and an enclosed space , 2009, Behavioural Brain Research.

[47]  J. Holst,et al.  GLP‐1: physiological effects and potential therapeutic applications , 2008, Diabetes, obesity & metabolism.

[48]  G. Jensen,et al.  Comparison of chemical and cell-based antioxidant methods for evaluation of foods and natural products: generating multifaceted data by parallel testing using erythrocytes and polymorphonuclear cells. , 2008, Journal of agricultural and food chemistry.

[49]  Frauke Zipp,et al.  The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases , 2006, Trends in Neurosciences.

[50]  Tam Doan,et al.  Antagonistic Effects of β-Site Amyloid Precursor Protein-cleaving Enzymes 1 and 2 on β-Amyloid Peptide Production in Cells* , 2003, Journal of Biological Chemistry.

[51]  D. Ginty,et al.  Function and Regulation of CREB Family Transcription Factors in the Nervous System , 2002, Neuron.

[52]  M. Fioravanti,et al.  Nicergoline for dementia and other age associated forms of cognitive impairment , 2001 .

[53]  S. Baskin,et al.  Cardiotonic drugs inhibit purified mammalian acetylcholinesterase , 1991, Journal of applied toxicology : JAT.

[54]  F. Petruch,et al.  Cyclobarbital as a test substance for oxidative drug metabolism in man. Findings in neuropsychiatric patients , 1979, European Journal of Clinical Pharmacology.

[55]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[56]  D. SathisKumar,et al.  Nootropic and Antibacterial Activity of Methanolic Piper trioicum Roxb Extracts , 2013 .

[57]  S. Yılmazer,et al.  A novel perspective for Alzheimer's disease: vitamin D receptor suppression by amyloid-β and preventing the amyloid-β induced alterations by vitamin D in cortical neurons. , 2011, Journal of Alzheimer's disease : JAD.

[58]  D. Banji,et al.  Inhibitory effects of ethanolic extract of Piper trioicum on amylase, lipase and α-glucosidase. , 2010 .

[59]  A. A. Rao,et al.  Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease. , 2007, Medical hypotheses.

[60]  R. Vassar.  β-Secretase, APP and Aβ in Alzheimer’s Disease , 2005 .

[61]  B T Hyman,et al.  beta-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with aging. , 2001, The American journal of pathology.

[62]  E. Giacobini.  Selective Inhibitors of Butyrylcholinesterase , 2001 .